ArticleExperimental hematology & oncology2022

Immunotherapy in patients with metastatic castration-resistant prostate cancer: a meta-analysis of data from 7 phase III studies and 3 phase II studies.

Anqiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.